Social media users have expressed frustration over the steep rise in hostel fees at KNUST for the 2025/2026 academic year Comparisons show that while St Theresa’s Hostel previously led with high ...

A letter of recommendation can make all the difference when candidates are applying for their dream job. It serves as a powerful tool for highlighting an individual's unique qualities, achievements, ...

NASA's beleaguered Mars Sample Return program currently faces extreme costs of up to $11 billion and a timeline that could reach 2040. The year 2025 isn't even a week old and NASA is already ...

Global access to international food markets is still unequal and driven by trade and non-trade frictions. A new global cost analysis of the trade of grains highlights the importance of different ...

Kwame Nkrumah University of Science and Technology (KNUST) will be closing its admissions portal today, January 3. Kwame Nkrumah University of Science and Technology and University Of Ghana are ...

NASA wants to return Mars samples to Earth, but budget problems and technical woes have the mission caught between a rock and the Red Planet. There appears to be an unofficial robotic space race ...

Investopedia / Michela Buttignol The aim of applied economics is to inform economic decisions and predict possible outcomes. Applied economics relates the conclusions drawn from economic theories ...

Environmental economics is the study of the economics of ecological and environmental issues. It focuses on the monetary value of ecosystems and the costs and benefits of environmental policies.

Also, check out the samples to learn about the right ways to structure the Leave application letter. It is a formal request submitted to an employer or supervisor, seeking permission to be absent from ...

On the economics of groceries. Warning: There is a little math involved. Let’s say you have a roadside farmer’s market and you are selling ears of corn for a dollar each. You have 75 cents in ...

Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...